GR3022183T3 - Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation - Google Patents

Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation

Info

Publication number
GR3022183T3
GR3022183T3 GR960403651T GR960403651T GR3022183T3 GR 3022183 T3 GR3022183 T3 GR 3022183T3 GR 960403651 T GR960403651 T GR 960403651T GR 960403651 T GR960403651 T GR 960403651T GR 3022183 T3 GR3022183 T3 GR 3022183T3
Authority
GR
Greece
Prior art keywords
treatment
blood circulation
atoms
radical
muscle damage
Prior art date
Application number
GR960403651T
Other languages
English (en)
Inventor
Ismahan Dr Okyayuz-Baklouti
Maurice Dr Mars
Michael Alfred Gregory
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR3022183T3 publication Critical patent/GR3022183T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GR960403651T 1992-02-22 1996-12-30 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation GR3022183T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4205424 1992-02-22

Publications (1)

Publication Number Publication Date
GR3022183T3 true GR3022183T3 (en) 1997-03-31

Family

ID=6452327

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960403651T GR3022183T3 (en) 1992-02-22 1996-12-30 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation

Country Status (13)

Country Link
EP (1) EP0557876B1 (el)
JP (1) JP3193800B2 (el)
KR (1) KR930017580A (el)
AT (1) ATE146078T1 (el)
AU (1) AU658979B2 (el)
CA (1) CA2089959A1 (el)
DE (1) DE59304710D1 (el)
DK (1) DK0557876T3 (el)
ES (1) ES2096115T3 (el)
GR (1) GR3022183T3 (el)
HU (1) HUT64472A (el)
TW (1) TW288977B (el)
ZA (1) ZA931184B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3792266B2 (ja) * 1994-06-16 2006-07-05 森精機興産株式会社 工作機械の熱変位補正方法及びその装置
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US20070105878A1 (en) * 2005-10-03 2007-05-10 Andrew Reaume Purine formulations and methods for managing disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (el) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
DK0484785T3 (da) * 1990-11-07 1996-09-23 Hoechst Marion Roussel Inc Anvendelse af xanthiner til fremstilling af et lægemiddel, der er virksomt til inhibering af formeringen af humane retrovira

Also Published As

Publication number Publication date
EP0557876A1 (de) 1993-09-01
JPH069634A (ja) 1994-01-18
HU9300476D0 (en) 1993-05-28
DE59304710D1 (de) 1997-01-23
ZA931184B (en) 1993-09-16
AU3376193A (en) 1993-08-26
AU658979B2 (en) 1995-05-04
ATE146078T1 (de) 1996-12-15
TW288977B (el) 1996-10-21
ES2096115T3 (es) 1997-03-01
HUT64472A (en) 1994-01-28
KR930017580A (ko) 1993-09-20
CA2089959A1 (en) 1993-08-23
EP0557876B1 (de) 1996-12-11
JP3193800B2 (ja) 2001-07-30
DK0557876T3 (da) 1997-05-26

Similar Documents

Publication Publication Date Title
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
HU896769D0 (en) Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients
SE9100342D0 (sv) Novel steroid esters
ATE73790T1 (de) Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AU584274B2 (en) Process for the crosslinking of organopolysiloxanes
TW288977B (el)
IL91913A0 (en) Fluorosubstituted benzene derivatives,processes for the preparation thereof and diagnostic compositions containing the same
ZA918801B (en) Use of xanthinges for the preparation of a medicament effective for inhibiting the replication of human retroviruses
AU6016590A (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
DE3855902D1 (de) Herstellungsverfahren für 2,5-Diamino-6-nitro-pyridinderivate sowie neue 2,5-Diamino-6-nitro-pyridinderivate
CA2030732A1 (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
NZ216125A (en) Isoxazoles and pharmaceutical compositions
PL242536A1 (en) Process for preparing novel derivatives of oxazinebenzothiazine 6,6-dioxide
ES2096800T3 (es) Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
IL93178A0 (en) Benzheterocyclyl sulphones
IL69710A (en) Preparation of vinyl carbamates and certain such novel compounds
HUT55013A (en) Process for producing substituted 20,21-dinoreburnamenine
FR2481697B1 (el)